New as of today. The ISMP Medication Safety Alert, August 10, 2006 - Volume 11 Issue 16.
The Institute for Safe Medication Practice. Action needed to prevent serious tissue injury with IV promethazine. "However, due to the frequency of severe, tragic, local injuries after infiltration or inadvertent intra-arterial injection, ISMP recommends that the FDA reexamine the product labeling and consider eliminating the IV route of administration." Reference newspaper article: http://www.thedailyworld.com/articles/2005/12/07/local_news/02news.txt Please email me privately and I will send you the pdf newsletter as an attachement. This is pretty good material to stop the use of IV Phenergan. Timothy Royer, BSN, CRNI Nurse Manager / Vascular Access / Diagnostic Service VA Puget Sound Health Care System Seattle / American Lake Divisions, WA
